Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-VEGF Treatment in Patients With Age-Related Macular Degeneration
This study has been completed.
Study NCT00511706 Information provided by Allergan
First Received: August 2, 2007 Last Updated: June 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Choroidal Neovascularization
Age-Related Maculopathy
Additional conditions recognized in this trial
Macular Degeneration
Neovascularization, Pathologic
More general conditions related to this trial
Choroid Diseases
Eye Diseases
Metaplasia
Pathologic Processes
Retinal Degeneration
Retinal Diseases
Uveal Diseases
Interventions listed in this trial
Dexamethasone and ranibizumab
Sham injection and ranibizumab
Additional drug interventions recognized in this trial
Dexamethasone
Dexamethasone acetate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Allergan
Back to top of Main Content
